Alexion Pharmaceuticals Inc.

NMS : ALXN
Chemicals
Cheshire CT
Revenue (US$ Millions)$2,234
Revenue Growth (%)43.99%
Net Income (Millions)$657
Common Shares Outstanding (Millions)$199
Earnings per Share$3.26
Price To Earnings Ratio60.48
Total Equity (Millions)$3,302
Profit Margin 129.41%
Return on Equity27.58%
Long Term Debt (US$ Millions)$117
Debt To Equity Ratio (%)0.04%
Market Capitalization (US$ Millions)$36,831
Total Assets (US$ Millions)$4,202
Return on Assets (%)19.8
Current Assets (US$ Millions)$2,796
Inventories (US$ Millions)$176
Current Liabilities (US$ Millions)$607
Cost of Goods Sold (US$ Millions)$174
Asset Turnover0.53
Inventory Turnover1.25